Description
The THCGME Program provides continuation funding to existing HRSA‑supported primary‑care residency programs located in community‑based ambulatory health centers. Only current HRSA THCGME recipients may apply for a two‑year extension (July 2027 – June 2029) to maintain resident Full‑Time Equivalent (FTE) positions. Awards range from $320,000 to $2,880,000 per recipient, with an estimated total FY 2027 funding pool of $20.96 million across 12 awards. Applications are due 11:59 p.m. ET on 12 Nov 2026; the expected award notice is 1 July 2027. Eligible entities are community‑based health centers or GME consortia that operate accredited primary‑care residency programs in listed specialties (e.g., Family Medicine, Internal Medicine, Pediatrics, etc.). No cost‑sharing is required, and funds may only be used for direct and indirect expenses associated with resident training.
• Open to current HRSA THCGME recipients (must have received HRSA‑23‑013 funding).
• Eligible specialties: Family Medicine, Internal Medicine, Pediatrics, IM‑Pediatrics, OB‑GYN, Psychiatry, General Dentistry, Pediatric Dentistry, Geriatrics.
• Funding period: 07/01/2027 – 06/30/2029 (two 12‑month budget periods).
• Award size: $320,000 – $2,880,000 per award; total FY 2027 funding $20.96 M.
• Application deadline: 12/11/2026 (11:59 p.m. ET).
• Required registrations: Active SAM.gov (UEI) and Grants.gov accounts.
• Reporting & compliance: Annual reconciliation, FTE verification, adherence to HRSA and HHS regulations.
• No new residency positions may be created; only continuation of previously approved FTEs is allowed.